全球代謝體學市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計代謝體學市場將從 2025 年的 39.2 億美元成長到 2034 年的 112.9 億美元，2026 年至 2034 年的複合年成長率為 12.46%。

由於人們對個人化醫療和疾病研究的興趣日益濃厚，全球代謝體學市場正經歷快速成長。代謝體學研究生物系統中的小分子，有助於科學家了解疾病機制並識別生物標記。對藥物研發和生物技術投入的增加正在推動對代謝體學技術的需求。

此外，質譜和核磁共振（NMS）技術的進步正在推動市場發展。這些工具能夠對複雜的生物樣本進行精確分析，從而支持藥物研發和臨床診斷。隨著人們對疾病早期檢測和精準醫療的日益關注，代謝體學在研究和醫療機構中的應用正在加速成長。

展望未來，人工智慧（AI）與巨量資料分析的融合有望提升數據解讀與研究成果。代謝組學在營養學、毒理學和環境研究等領域的應用拓展將進一步擴大市場規模。隨著技術的持續創新和醫療保健投資的不斷成長，預計代謝體學市場在未來幾年將保持強勁成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球代謝體學市場：依產品與服務分類

• 市場分析、洞察與預測
• 代謝體學學設備
• 代謝體學和生物資訊學工具及服務

第5章：全球代謝體學市場：依應用分類

• 市場分析、洞察與預測
• 生物標記發現
• 藥物發現
• 毒性測試
• 營養基因體學
• 功能基因體學
• 個人化醫療
• 其他用途

第6章：全球代謝體學市場：依適應症分類

• 市場分析、洞察與預測
• 癌症
• 心血管疾病
• 神經系統疾病
• 先天性代謝缺陷
• 其他跡象

第7章 全球代謝體學市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Biocrates Life Sciences AG
  • Shimadzu Corporation
  • Bio-Rad Laboratories Inc
  • Waters Corporation
  • Danaher Corporation
  • Bruker Corporation
  • LECO Corporation
  • Agilent Technologies Inc
  • Human Metabolome Technologies Inc
  • Metabolon Inc

The Metabolomics Market size is expected to reach USD 11.29 Billion in 2034 from USD 3.92 Billion (2025) growing at a CAGR of 12.46% during 2026-2034.

The Global Metabolomics Market is witnessing rapid growth due to rising interest in personalized medicine and advanced disease research. Metabolomics studies small molecules in biological systems, helping scientists understand disease mechanisms and identify biomarkers. Increasing investments in pharmaceutical research and biotechnology are fueling demand for metabolomics technologies.

The market is also driven by technological advancements in mass spectrometry and nuclear magnetic resonance techniques. These tools enable accurate analysis of complex biological samples, supporting drug discovery and clinical diagnostics. Growing focus on early disease detection and precision healthcare is encouraging the use of metabolomics in research laboratories and healthcare institutions.

Looking ahead, integration of artificial intelligence and big data analytics is expected to enhance data interpretation and research outcomes. Expanding applications in nutrition, toxicology, and environmental studies will further broaden market scope. With continuous innovation and rising healthcare investments, the metabolomics market is expected to maintain strong growth momentum in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Services

• Metabolomics Instruments
• Metabolomics Bioinformatics Tools and Services

By Application

• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics
• Personalized Medicine
• Other Applications

By Indication

• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Other Indications

COMPANIES PROFILED

• Biocrates Life Sciences AG, Shimadzu Corporation, BioRad Laboratories Inc, Waters Corporation, Danaher Corporation, Bruker Corporation, LECO Corporation, Agilent Technologies Inc, Human Metabolome Technologies Inc, Metabolon Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL METABOLOMICS MARKET: BY PRODUCT AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Services
• 4.2. Metabolomics Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Metabolomics Bioinformatics Tools and Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL METABOLOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Biomarker Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Toxicology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nutrigenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Functional Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL METABOLOMICS MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Inborn Errors of Metabolism Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL METABOLOMICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product And Services
  • 7.2.2 By Application
  • 7.2.3 By Indication
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product And Services
  • 7.3.2 By Application
  • 7.3.3 By Indication
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product And Services
  • 7.4.2 By Application
  • 7.4.3 By Indication
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product And Services
  • 7.5.2 By Application
  • 7.5.3 By Indication
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product And Services
  • 7.6.2 By Application
  • 7.6.3 By Indication
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL METABOLOMICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Biocrates Life Sciences AG
  • 9.2.2 Shimadzu Corporation
  • 9.2.3 Bio-Rad Laboratories Inc
  • 9.2.4 Waters Corporation
  • 9.2.5 Danaher Corporation
  • 9.2.6 Bruker Corporation
  • 9.2.7 LECO Corporation
  • 9.2.8 Agilent Technologies Inc
  • 9.2.9 Human Metabolome Technologies Inc
  • 9.2.10 Metabolon Inc